### Analysis

The earnings call for UnitedHealth Group revealed a strong performance for the first quarter of 2016, with notable growth in revenue and earnings. The company highlighted its focus on quality and customer satisfaction, which has driven organic growth and increased customer retention. Optum's growth was particularly impressive, with a 54% increase in revenue year-over-year.

However, there were some concerns raised about the impact of individual exchange business on earnings, with an additional $125 million added to reserves to account for potential losses. The company also mentioned that it would not carry financial exposure from exchanges into 2017, a decision that could have a significant impact on earnings and stock price.

Overall, the call provided a mix of positive and negative signals. The strong performance in revenue and earnings, along with the company's focus on quality and customer satisfaction, suggests that the stock could see some positive impact in the short term. However, the uncertainty around the individual exchange business and the potential for earnings pressure could lead to some volatility in the stock price.

### Conclusion

The short-term impact on the stock price of UnitedHealth Group is likely to be neutral to slightly positive, given the strong first quarter performance and the company's focus on quality and customer satisfaction. However, the uncertainty around the individual exchange business and the potential for earnings pressure could lead to some volatility in the stock price.

**Rating: 0**